Exercise Science

Muscle Mass & Weight Loss Drugs: Overblown Fears or Justified Concerns?

Exercise Science

Show Notes

Semaglutide, sold as Ozempic and Wegovy, and tirzepatide, sold as Zepbound and Mounjaro, are new weight loss drugs that actually work, helping millions around the world to feel better and become healthier. But some people are fearful of side effects, such as loss of muscle mass. Are their fears warranted? To find out, Marty and Stu talk to the two University of Kansas weight-loss scientists, Renee Rogers and ACSM president-elect John Jakicic, who are leading a clinical trial investigating the way aerobic and resistance training can affect the muscle mass of people who are on GLP-1s, or the other new weight loss drugs. In this episode: —how GLP-1s affect muscle mass —the difference between lean and muscle mass —the research that Jakicic and Rogers are doing into GLP-1s —guidance on whether people should be concerned about GLP-1s and muscle mass —how to minimize muscle loss while on GLP-1s Plus, whether the new weight loss drugs affect men and women differently. Have a listener question? Email us at [email protected] Exercise Science is powered by EverMe, the longevity intelligence app. Exercise Science listeners get a free two-month trial to EverMe at this link. You can also download EverMe for free at your favourite app store. Exercise Science sponsor Precision Nutrition is the #1 most recommended nutrition certification program in the world. And now it specializes in GLP-1 coaching. For a free assessment to learn your GLP-1 type, visit GLPCoaching.com.

LINKS Follow or subscribe at your favourite platform @realexercisescience: Substack. YouTube. TikTok. Instagram. Apple Podcasts. Spotify. On X you can find us @realexscience. Stu is everywhere, too, but mostly on Instagram and X. Follow him on TikTok too! Marty just started his own Instagram. Give him a follow! He’s also on X! Exercise Science is produced by Ghost Bureau, the Toronto content agency. EPISODE LINKS New York Times: They Hated Exercise. Weight Loss Drugs Changed Everything. Renee Rogers and John Jakicic’s clinical trial: Muscle and Movement With Anti-Obesity Medications (M3) A paper by John Jakicic and Renee Rogers advocating for a prescription of exercise along with obesity medication: The Role of Exercise in the Contemporary Era of Obesity Management Medications Jakicic led, and Rogers coauthored, the largest NIH investment into how physical activity improves health and prevents disease. Study website. Journal article: Molecular Transducers of Physical Activity Consortium (MoTrPAC): human studies design and protocol Analysis: Preserving muscle mass on GLP-1 weight loss drugs: Big Deal or Nothing to Worry About? By Stuart Phillips DISCUSSION POINTS 00:00 Cold open 01:29 Muscle mass and GLP-1s 04:19 Introducing Renee and John 06:19 GLP-1 context 07:50 How GLP-1s work 10:50 More than GLP-1s 12:44 Body composition & weight loss 15:00 Lean tissue is not muscle 16:50 Overblown fears 18:55 Muscle moment 20:39 R01 study described 23:15 Early results 26:04 Behavioural influences 28:45 Rediscovering exercise 31:09 Comprehensive care 33:00 Renting weight loss 36:55 Obesity drivers 37:47 Older adults 40:39 Wraparound care 41:30 Muscle health context 43:12 Function measures matter 44:44 Lean v. muscle 46:15 Unloading the body 47:40 GLP-1 sex differences 49:44 How to minimize muscle loss on GLP-1s 53:33 Wrap up

DISCLAIMER The Exercise Science podcast is for educational and entertainment purposes only and is not a substitute for professional medical advice. Strength training and fitness carry inherent risks. Always consult with a physician or qualified healthcare provider before starting any new exercise program or making changes to your diet. The hosts, producers, sponsors and guests of this podcast disclaim any liability for any injuries or losses connected with the information discussed in this show. Martin Gibala is an advisor to and holds equity in Longevity League Ltd., a US-based company whose services in part relate to exercise.

More from Exercise Science

Aug 18, 2026

In a special episode that concludes the first season of Exercise Science we invited on Gary LeBlanc, the COO and president of our title sponsor, EverMe, to discuss the future of wellness in our first-ever live taping in downtown Toronto. Gary LeBlanc has been studying wellness and personal optimization for decades. As a leader at EverMe, Gary and his team are creating an agentic AI that breaks down complex longevity research, trending topics and expert perspectives into evidence-backed guidance. It also tracks your wearable data and provides guidance on the best way to achieve your health goals. Together, Stu, Marty and Gary discuss: Orthometria, Stu’s term describing an obsession with correct measurement of the self

Aug 11, 2026

You’re a busy person. Career, family, social obligations and everything else. What SHOULD you be doing for your cardio if you have just five hours a week to devote to your training? What’s the proper mix of long, slow effort, interval sessions and tempo bouts? How many times a week should you be getting out? And what’s the ideal duration per workout? To work out the answer, Marty and Stu invite on to the show the science journalist Alex Hutchinson, who has a physics Ph.D. from Cambridge and was on the Canadian national running team. He writes the Sweat Science column, on the science of human performance, for Outside magazine. He’s also the author of the bestselling books Endure and The Explorer’s Gene. Together, the guys discuss: the challenge of cardio training when you’re not a professional athlete.

Aug 4, 2026

What’s the most efficient way to fuel human performance during endurance sports? Australian Louise Burke is one of the best-known sports nutritionists on the planet, known for her Supernova race-walking studies that showed that keto- and low carb, high fat diets don’t fuel endurance athletes as well as carbohydrate-burning approaches. She also practices what she researches, holding the women’s Australian marathon record in her age group—the age group, she jokes, of “never you mind.” In this episode Dr. Burke walks Stu and Marty through her research that found carb-based approaches to fueling yield about 5% more of the muscle cell’s energy currency, ATP, compared to fat-burning approaches, with carb-burning also yielding 7-8% better performance. She also: —discusses her own approach to fuelling endurance events —provides tips on carbohydrate periodization —answers a listener question about carb-loading —shows that carbs during a race are good for the brain

Jul 28, 2026

You have an older person in your life, or perhaps you are an older person yourself and you need that push to start strength training. This is the episode for you—because today we’re talking with Ashley Gluchowski, Ph.D., one of the most enthusiastic evangelists on strength training around and the University of Salford exercise scientist who helps older adults get stronger, improve balance and reduce risk of falls. In this episode we discuss: The surprising activities of daily living that require strength as we get older Why older adults should be doing strength training The association between strength and decreased dementia risk

Jul 21, 2026

It’s no longer just the longevity bros and fitness fiends obsessing over their protein intake. So what does the science actually say about protein consumption? How much do you need, and what’s the best way to get it? In today’s episode, Marty takes our own in-house world-renowned protein expert Stuart Phillips through the math behind the macros. In this episode Stu and Marty discuss: Stu says why the old guideline of 0.8 g/kg body weight wasn’t enough

See all episodes →